ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares, rose in value, with the stock price up by 3.92% to the previous day’s close as strong demand from buyers drove the stock to $0.74.
Actively observing the price movement in the last trading, the stock closed the session at $0.71. The value of beta (5-year monthly) was 0.58. Referring to stock’s 52-week performance, its high was $90.65, and the low was $0.50. On the whole, ZVSA has fluctuated by -13.91% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.37, which is expected to increase to -$0.22 for fiscal year -$1.5 and then to about -$9.49 by fiscal year 2025. Data indicates that the EPS growth is expected to be 98.60% in 2025, while the next year’s EPS growth is forecast to be -532.70%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ZVSA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ZVSA currently trading nearly -7.86% and -0.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.87, while the 7-day volatility ratio is showing 9.43% which for the 30-day chart, stands at 12.55%. Furthermore, ZyVersa Therapeutics Inc (ZVSA)’s beta value is 0.56, and its average true range (ATR) is 0.11.
A comparison of ZyVersa Therapeutics Inc (ZVSA) with its peers suggests the former has fared considerably weaker in the market. ZVSA showed an intraday change of 3.92% in last session, and over the past year, it shrunk by -98.89%%.
Data on historical trading for ZyVersa Therapeutics Inc (NASDAQ:ZVSA) indicates that the trading volumes over the past 10 days have averaged 0.35 million and over the past 3 months, they’ve averaged 2.75 million. According to company’s latest data on outstanding shares, there are 7.59 million shares outstanding.
Nearly 5.41% of ZyVersa Therapeutics Inc’s shares belong to company insiders and institutional investors own 13.75% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.65 million shares as on Mar 15, 2024, resulting in a short ratio of 0.1. According to the data, the short interest in ZyVersa Therapeutics Inc (ZVSA) stood at 8.51% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.17 million. The stock has fallen by -17.73% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZVSA stock heading into the next quarter.
